Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (261-270 of 349) with videos related to

Pageof 35
Sort By:
Urology|April 5, 2008
Effect of DNA methylation on identification of aggressive prostate cancerJoshi J Alumkal, Zhe Zhang, Elizabeth B Humphreys, et al.
The Journal of Urology|January 25, 2021
Transperineal Prostate Biopsy Improves the Detection of Clinically Significant Prostate Cancer among Men on Active SurveillanceAlexa R Meyer, Mufaddal Mamawala, Jared S Winoker, et al.
Urology|June 18, 2003
Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancerJohn J Hlavaty, Alan W Partin, Matthew J Shue, et al.
The Journal of Urology|February 26, 2008
PCA3: a molecular urine assay for predicting prostate biopsy outcomeIna L Deras, Sheila M J Aubin, Amy Blase, et al.
Prostate Cancer and Prostatic Diseases|August 22, 2020
A novel method for detection of exfoliated prostate cancer cells in urine by RNA in situ hybridizationJillian N Eskra, Daniel Rabizadeh, Leslie Mangold, et al.
The Journal of Urology|April 29, 2014
Obesity and long-term survival after radical prostatectomyHeather J Chalfin, Seung Bae Lee, Byong Chang Jeong, et al.
Urology|December 15, 2004
Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%Masood A Khan, Lori J Sokoll, Daniel W Chan, et al.
Proteomics|November 5, 2003
Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivityKerri Bouwman, Ji Qiu, Heping Zhou, et al.
Cancer Research|January 2, 2009
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancerRong Hu, Thomas A Dunn, Shuanzeng Wei, et al.
Transfusion|March 8, 2014
Allogeneic versus autologous blood transfusion and survival after radical prostatectomyHeather J Chalfin, Steven M Frank, Zhaoyong Feng, et al.
Pageof 35

Showing results (261-270 of 349) with videos related to

Sort By:
Pageof 35
Urology|April 5, 2008
Effect of DNA methylation on identification of aggressive prostate cancerJoshi J Alumkal, Zhe Zhang, Elizabeth B Humphreys, et al.
The Journal of Urology|January 25, 2021
Transperineal Prostate Biopsy Improves the Detection of Clinically Significant Prostate Cancer among Men on Active SurveillanceAlexa R Meyer, Mufaddal Mamawala, Jared S Winoker, et al.
Urology|June 18, 2003
Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancerJohn J Hlavaty, Alan W Partin, Matthew J Shue, et al.
The Journal of Urology|February 26, 2008
PCA3: a molecular urine assay for predicting prostate biopsy outcomeIna L Deras, Sheila M J Aubin, Amy Blase, et al.
Prostate Cancer and Prostatic Diseases|August 22, 2020
A novel method for detection of exfoliated prostate cancer cells in urine by RNA in situ hybridizationJillian N Eskra, Daniel Rabizadeh, Leslie Mangold, et al.
The Journal of Urology|April 29, 2014
Obesity and long-term survival after radical prostatectomyHeather J Chalfin, Seung Bae Lee, Byong Chang Jeong, et al.
Urology|December 15, 2004
Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%Masood A Khan, Lori J Sokoll, Daniel W Chan, et al.
Proteomics|November 5, 2003
Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivityKerri Bouwman, Ji Qiu, Heping Zhou, et al.
Cancer Research|January 2, 2009
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancerRong Hu, Thomas A Dunn, Shuanzeng Wei, et al.
Transfusion|March 8, 2014
Allogeneic versus autologous blood transfusion and survival after radical prostatectomyHeather J Chalfin, Steven M Frank, Zhaoyong Feng, et al.
Pageof 35